ARTIVION, INC. (AORT)
$25.70-$1.07 (-4.00%) TodayExtended Hours
James P. Mackin - Officer
Amy Horton - OfficerArtivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 116,309 | $3.00M |
| Option exercise | 4 | 88,002 | |
| Other acquisition / disposition | 2 | 12,650 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
65 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James P. Mackin - Officer | Open-market sale | Common Stock | 70,000 | $28.96 | $2.03M | |
| Andrew M. Green - Officer | Open-market sale | Common Stock | 616 | $28.55 | $18K | |
| Lance A. Berry - Officer | Open-market sale | Common Stock | 715 | $28.55 | $20K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 977 | $28.49 | $28K | |
| Andrew M. Green - Officer | Option exercise | Stock Options (Right to buy) | 14,001 | $0.00 | - | |
| Andrew M. Green - Officer | Option exercise | Stock Options (Right to buy) | 30,000 | $0.00 | - | |
| Andrew M. Green - Officer | Option exercise | Common Stock | 14,001 | $18.44 | $258K | |
| Andrew M. Green - Officer | Open-market sale | Common Stock | 14,001 | $20.71 | $290K | |
| Andrew M. Green - Officer | Option exercise | Common Stock | 30,000 | $11.03 | $331K | |
| Andrew M. Green - Officer | Open-market sale | Common Stock | 30,000 | $20.69 | $621K | |
 Anthony B. Semedo - Director | Other | Common Stock | 6,325 | $0.00 | - | |
| Anthony B. Semedo - Director | Other | Common Stock | 6,325 | $0.00 | - | |
 Marna P. Borgstrom - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
| Anthony B. Semedo - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
 Jon W. Salveson - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
| Elizabeth A. Hoff - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
| Jeffrey H. Burbank - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
| James Bullock - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
| Daniel J. Bevevino - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
| Thomas F. Ackerman - Director | Grant or award | Common Stock | 7,576 | $0.00 | - | |
| Marna P. Borgstrom - Director | Grant or award | Common Stock | 7,850 | $0.00 | - | |
| Amy Horton - Officer | Grant or award | Common Stock | 7,475 | $0.00 | - | |
| Amy Horton - Officer | Open-market sale | Common Stock | 901 | $37.78 | $34K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 8,962 | $38.00 | $341K | |
| Jean F. Holloway - Officer | Grant or award | Common Stock | 27,795 | $0.00 | - | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 3,843 | $37.78 | $145K | |
| Marshall S. Stanton - Officer | Grant or award | Common Stock | 21,838 | $0.00 | - | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 2,149 | $37.78 | $81K | |
| John E. Davis - Officer | Grant or award | Common Stock | 28,845 | $0.00 | - | |
| John E. Davis - Officer | Open-market sale | Common Stock | 4,573 | $37.78 | $173K | |
| Lance A. Berry - Officer | Grant or award | Common Stock | 40,874 | $0.00 | - | |
| Lance A. Berry - Officer | Open-market sale | Common Stock | 6,316 | $37.78 | $239K | |
| James P. Mackin - Officer | Grant or award | Common Stock | 116,948 | $0.00 | - | |
| James P. Mackin - Officer | Open-market sale | Common Stock | 17,887 | $37.78 | $676K | |
| Amy Horton - Officer | Open-market sale | Common Stock | 641 | $38.02 | $24K | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 1,513 | $38.02 | $58K | |
| James P. Mackin - Officer | Open-market sale | Common Stock | 14,911 | $38.02 | $567K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 2,183 | $38.02 | $83K | |
| Lance A. Berry - Officer | Open-market sale | Common Stock | 5,178 | $38.02 | $197K | |
| John E. Davis - Officer | Open-market sale | Common Stock | 2,784 | $38.02 | $106K | |
| Amy Horton - Officer | Open-market sale | Common Stock | 1,731 | $37.59 | $65K | |
| Amy Horton - Officer | Open-market sale | Common Stock | 830 | $35.69 | $30K | |
| Amy Horton - Officer | Grant or award | Common Stock | 5,658 | $0.00 | - | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 2,423 | $37.59 | $91K | |
| Marshall S. Stanton - Officer | Open-market sale | Common Stock | 1,259 | $35.69 | $45K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 3,079 | $37.59 | $116K | |
| Jean F. Holloway - Officer | Open-market sale | Common Stock | 1,668 | $35.69 | $60K | |
| Jean F. Holloway - Officer | Grant or award | Common Stock | 20,085 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Stanton Marshall S. | Officer | 7,400 | $199K | View on EDGAR | |
| Mackin James P | Officer | 70,000 | $2.05M | View on EDGAR | |
| Berry Lance A | Officer | 715 | $20K | View on EDGAR |
ARTIVION, INC. (AORT) had 6 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for AORT runs to 65 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AORT were filed in the last 90 days.
6 insider sales of AORT were filed in the last 90 days, totaling $3.00M.
This page tracks AORT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AORT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
